首页 > 最新文献

Klinicka mikrobiologie a infekcni lekarstvi最新文献

英文 中文
[Symptoms and complications of influenza A in seniors in the 2018-2019 season]. [2018-2019年老年人甲型流感的症状和并发症]。
Q3 Medicine Pub Date : 2020-03-01
Robin Šín, Dalibor Sedláček, Sam Hofman

Aims: To describe the symptoms and complications of influenza A in seniors in the 2018-2019 influenza season.

Material and methods: A retrospective analysis of data on 84 seniors with laboratory confirmed influenza A between 1 October 2018 and 30 April 2019 who were tested for this infectious disease in the University Hospital Pilsen.

Results: Influenza A was diagnosed in 84 seniors during the period under review. The most common symptoms were fever (69 cases; 82.14 %) and cough (60 cases; 71.43 %). These two symptoms combined occurred in more than half of patients over 65 years of age (51 cases; 60.71 %). Other common symptoms included general weakness (58 cases; 69.05 %) and fatigue (57 cases; 67.86 %). The other symptoms occurred in less than half of cases. The most common complication was pneumonia (36 cases; 42.86 %). Bacterial etiology was confirmed in 13 cases and the most commonly occurring pathogens were Klebsiella pneumoniae and Streptococcus pneumoniae. Another common complication of influenza was acute respiratory insufficiency in pneumonia, heart failure or exacerbation of chronic respiratory disease. The mortality rate of seniors in our sample was 17.86 % (15 cases).

Conclusion: In the senior population, the most common symptoms of influenza are a rapid onset of fever and dry cough. The study has confirmed that the most common complication is pneumonia. Furthermore, exacerbations of various chronic diseases of the cardiovascular and respiratory systems, worsening of chronic renal insufficiency and urinary tract infections were common. The most effective prevention of the development of influenza and its complications is the available quadrivalent vaccine.

目的:了解2018-2019年流感季节老年人甲型流感的症状和并发症。材料和方法:对2018年10月1日至2019年4月30日期间在皮尔森大学医院接受甲型流感实验室确诊的84名老年人的数据进行回顾性分析。结果:在本报告所述期间,84名老年人被诊断为甲型流感。最常见的症状是发热(69例;82.14%)和咳嗽(60例;71.43%)。这两种症状合并出现在65岁以上患者的一半以上(51例;60.71%)。其他常见症状包括全身无力(58例;69.05%)和疲劳(57例;67.86%)。其他症状出现在不到一半的病例中。最常见的并发症是肺炎(36例;42.86%)。确诊细菌性病因13例,最常见病原体为肺炎克雷伯菌和肺炎链球菌。流感的另一个常见并发症是肺炎引起的急性呼吸功能不全、心力衰竭或慢性呼吸道疾病加重。本组老年人死亡率为17.86%(15例)。结论:在老年人群中,流感最常见的症状是快速发烧和干咳。研究证实,最常见的并发症是肺炎。此外,心血管和呼吸系统的各种慢性疾病的恶化,慢性肾功能不全和尿路感染的恶化是常见的。预防流感及其并发症的最有效方法是使用现有的四价疫苗。
{"title":"[Symptoms and complications of influenza A in seniors in the 2018-2019 season].","authors":"Robin Šín,&nbsp;Dalibor Sedláček,&nbsp;Sam Hofman","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aims: </strong>To describe the symptoms and complications of influenza A in seniors in the 2018-2019 influenza season.</p><p><strong>Material and methods: </strong>A retrospective analysis of data on 84 seniors with laboratory confirmed influenza A between 1 October 2018 and 30 April 2019 who were tested for this infectious disease in the University Hospital Pilsen.</p><p><strong>Results: </strong>Influenza A was diagnosed in 84 seniors during the period under review. The most common symptoms were fever (69 cases; 82.14 %) and cough (60 cases; 71.43 %). These two symptoms combined occurred in more than half of patients over 65 years of age (51 cases; 60.71 %). Other common symptoms included general weakness (58 cases; 69.05 %) and fatigue (57 cases; 67.86 %). The other symptoms occurred in less than half of cases. The most common complication was pneumonia (36 cases; 42.86 %). Bacterial etiology was confirmed in 13 cases and the most commonly occurring pathogens were Klebsiella pneumoniae and Streptococcus pneumoniae. Another common complication of influenza was acute respiratory insufficiency in pneumonia, heart failure or exacerbation of chronic respiratory disease. The mortality rate of seniors in our sample was 17.86 % (15 cases).</p><p><strong>Conclusion: </strong>In the senior population, the most common symptoms of influenza are a rapid onset of fever and dry cough. The study has confirmed that the most common complication is pneumonia. Furthermore, exacerbations of various chronic diseases of the cardiovascular and respiratory systems, worsening of chronic renal insufficiency and urinary tract infections were common. The most effective prevention of the development of influenza and its complications is the available quadrivalent vaccine.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 1","pages":"25-29"},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38729238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bacteremia pathogens in the University Hospital Olomouc]. [奥洛穆茨大学医院菌血症病原体]。
Q3 Medicine Pub Date : 2020-03-01
Miroslava Htoutou Sedlaková, Kateřina Fišerová, Milan Kolář

Objectives: To provide an overview of the most common bacterial species isolated from blood cultures in the University Hospital Olomouc in the years 2015-2019 and their antibiotic resistance patterns.

Material and methods: The data were obtained from the laboratory information management system ENVIS LIMS. The results were analyzed retrospectively for the period from January 1, 2015 to December 31, 2019. Among positive blood cultures, the prevalence of bacterial species was assessed and the most frequent species were evaluated for resistance to selected antibiotics. Each sample was processed using standard microbiology methods with the MALDI-TOF MS system. Susceptibility to antibiotics was tested with the microdilution method according to the EUCAST recommendations.

Results: Over the study period, a total of 3 400 isolates from blood cultures were included. Coagulase-negative staphylococci were the most prevalent (37 %), followed by Escherichia coli (16 %), Klebsiella pneumoniae (9 %), Staphylococcus aureus (7 %), Streptococcus spp. (5 %), Pseudomonas aeruginosa (4 %), Enterobacter cloacae (2 %), Enterococcus faecalis (2 %) and Enterococcus faecium (2 %). Resistance of E. coli to 3rd generation cephalosporins, piperacillin/tazobactam, gentamicin and fluoroquinolones ranged from 7 % to 33 %. A high percentage of Klebsiella pneumoniae strains (33 %-65 %) was resistant to the above antibiotics. The prevalence of methicillin-resistant Staphylococcus aureus reached 3-7 %. Pseudomonas aeruginosa exhibited resistance to piperacillin/tazobactam, ceftazidime, cefepime, meropenem, ciprofloxacin and gentamicin ranging from 3 % to 46 %.

Conclusion: Knowing the prevalence of bacterial species from blood cultures and their antimicrobial resistance patterns is important for empirical antibiotic therapy in case of an existing infection. It is advisable to conduct such epidemiological studies as part of antibiotic stewardship.

目的:概述奥洛穆茨大学医院2015-2019年从血液培养中分离出的最常见细菌种类及其抗生素耐药性模式。材料和方法:数据来源于实验室信息管理系统ENVIS LIMS。对2015年1月1日至2019年12月31日的结果进行回顾性分析。在阳性血培养中,评估了细菌种类的流行情况,并评估了最常见的物种对选定抗生素的耐药性。每个样品采用标准微生物学方法,用MALDI-TOF质谱系统进行处理。采用微量稀释法,按照EUCAST建议进行抗生素药敏试验。结果:研究期间共检获血培养分离株3 400株。以凝固酶阴性葡萄球菌最多(37%),其次是大肠杆菌(16%)、肺炎克雷伯菌(9%)、金黄色葡萄球菌(7%)、链球菌(5%)、铜绿假单胞菌(4%)、阴沟肠杆菌(2%)、粪肠球菌(2%)和屎肠球菌(2%)。大肠杆菌对第三代头孢菌素、哌拉西林/他唑巴坦、庆大霉素和氟喹诺酮类药物的耐药率为7%至33%。肺炎克雷伯菌菌株对上述抗生素耐药的比例较高(33% ~ 65%)。耐甲氧西林金黄色葡萄球菌患病率达3- 7%。铜绿假单胞菌对哌拉西林/他唑巴坦、头孢他啶、头孢吡肟、美罗培南、环丙沙星和庆大霉素的耐药率为3%至46%。结论:了解血培养细菌种类的流行情况及其耐药模式对已有感染的经验性抗生素治疗具有重要意义。将此类流行病学研究作为抗生素管理的一部分是可取的。
{"title":"[Bacteremia pathogens in the University Hospital Olomouc].","authors":"Miroslava Htoutou Sedlaková,&nbsp;Kateřina Fišerová,&nbsp;Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>To provide an overview of the most common bacterial species isolated from blood cultures in the University Hospital Olomouc in the years 2015-2019 and their antibiotic resistance patterns.</p><p><strong>Material and methods: </strong>The data were obtained from the laboratory information management system ENVIS LIMS. The results were analyzed retrospectively for the period from January 1, 2015 to December 31, 2019. Among positive blood cultures, the prevalence of bacterial species was assessed and the most frequent species were evaluated for resistance to selected antibiotics. Each sample was processed using standard microbiology methods with the MALDI-TOF MS system. Susceptibility to antibiotics was tested with the microdilution method according to the EUCAST recommendations.</p><p><strong>Results: </strong>Over the study period, a total of 3 400 isolates from blood cultures were included. Coagulase-negative staphylococci were the most prevalent (37 %), followed by Escherichia coli (16 %), Klebsiella pneumoniae (9 %), Staphylococcus aureus (7 %), Streptococcus spp. (5 %), Pseudomonas aeruginosa (4 %), Enterobacter cloacae (2 %), Enterococcus faecalis (2 %) and Enterococcus faecium (2 %). Resistance of E. coli to 3rd generation cephalosporins, piperacillin/tazobactam, gentamicin and fluoroquinolones ranged from 7 % to 33 %. A high percentage of Klebsiella pneumoniae strains (33 %-65 %) was resistant to the above antibiotics. The prevalence of methicillin-resistant Staphylococcus aureus reached 3-7 %. Pseudomonas aeruginosa exhibited resistance to piperacillin/tazobactam, ceftazidime, cefepime, meropenem, ciprofloxacin and gentamicin ranging from 3 % to 46 %.</p><p><strong>Conclusion: </strong>Knowing the prevalence of bacterial species from blood cultures and their antimicrobial resistance patterns is important for empirical antibiotic therapy in case of an existing infection. It is advisable to conduct such epidemiological studies as part of antibiotic stewardship.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 1","pages":"4-11"},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38716848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Our experience in laboratory diagnosis of rotaviruses]. [我们在轮状病毒实验室诊断方面的经验]。
Q3 Medicine Pub Date : 2019-12-01
Monika Dvořáková Heroldová, Romana Moutelíková, Veronika Holá, Milada Dvořáčková, Jana Prodělalová

Objective: Group A rotavirus (RVA) is one of leading causes of gastroenteritis in children under five years of age and is also an important nosocomial pathogen. In Europe, the most prevalent genotypes of RVA are G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8]. Severe dehydration is the most important complication of RVA gastroenteritis. Each year, rotavirus infection is responsible for 3,000 to 5,000 hospitalizations of children in the Czech Republic. The aim of this study was to detect rotaviruses in patients with suspected acute viral gastroenteritis.

Methods: A total of 1 566 stool samples were obtained from patients with acute gastroenteritis from March 2016 to December 2018. All samples were tested by the enzyme immunoassay, rapid immunochromatographic test and quantitative reverse transcription PCR assay to detect RVA. All RVA positive samples were G- and P-typed by Sanger sequencing.

Results and conclusion: RVA was detected in 13.7 % of the samples (214/1566). The incidence of RVA was 58.9 % (126/214) in males and 41.1 % (88/214) in females. The percentages of positivity ranged from 1 % to 33 % in different age groups. The highest proportion of positive patients was in the age group 4-5 years, 32.6 % (30/92). There was a significant difference in the incidence of rotaviruses between different age groups (p = 0.3946). The prevalent RVA genotypes were G1P[8], G9P[8], G3P[8], G2P[4] and G8P[8]. The detection of the G8P[8] genotype was unusual. The obtained results show that despite the possibility of vaccination, the incidence of RVA infection remains high in the Czech Republic.

目的:A群轮状病毒(RVA)是5岁以下儿童胃肠炎的主要病因之一,也是重要的医院病原菌。在欧洲,RVA最常见的基因型是G1P[8]、G2P[4]、G3P[8]、G4P[8]、G9P[8]和G12P[8]。严重脱水是RVA胃肠炎最重要的并发症。在捷克共和国,轮状病毒感染每年造成3 000至5 000名儿童住院。本研究的目的是检测疑似急性病毒性胃肠炎患者的轮状病毒。方法:收集2016年3月至2018年12月急性胃肠炎患者粪便标本1 566份。所有样品均采用酶免疫分析法、快速免疫层析法和定量反转录PCR法检测RVA。所有RVA阳性样本经Sanger测序均为G型和p型。结果与结论:RVA检出率为13.7%(214/1566)。男性RVA发生率为58.9%(126/214),女性为41.1%(88/214)。不同年龄组的阳性百分比从1%到33%不等。4 ~ 5岁年龄组阳性比例最高,为32.6%(30/92)。轮状病毒在不同年龄组间的发病率差异有统计学意义(p = 0.3946)。常见的RVA基因型为G1P[8]、G9P[8]、G3P[8]、G2P[4]和G8P[8]。G8P[8]基因型检测不常见。所获得的结果表明,尽管有可能接种疫苗,RVA感染的发病率在捷克共和国仍然很高。
{"title":"[Our experience in laboratory diagnosis of rotaviruses].","authors":"Monika Dvořáková Heroldová,&nbsp;Romana Moutelíková,&nbsp;Veronika Holá,&nbsp;Milada Dvořáčková,&nbsp;Jana Prodělalová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Group A rotavirus (RVA) is one of leading causes of gastroenteritis in children under five years of age and is also an important nosocomial pathogen. In Europe, the most prevalent genotypes of RVA are G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8]. Severe dehydration is the most important complication of RVA gastroenteritis. Each year, rotavirus infection is responsible for 3,000 to 5,000 hospitalizations of children in the Czech Republic. The aim of this study was to detect rotaviruses in patients with suspected acute viral gastroenteritis.</p><p><strong>Methods: </strong>A total of 1 566 stool samples were obtained from patients with acute gastroenteritis from March 2016 to December 2018. All samples were tested by the enzyme immunoassay, rapid immunochromatographic test and quantitative reverse transcription PCR assay to detect RVA. All RVA positive samples were G- and P-typed by Sanger sequencing.</p><p><strong>Results and conclusion: </strong>RVA was detected in 13.7 % of the samples (214/1566). The incidence of RVA was 58.9 % (126/214) in males and 41.1 % (88/214) in females. The percentages of positivity ranged from 1 % to 33 % in different age groups. The highest proportion of positive patients was in the age group 4-5 years, 32.6 % (30/92). There was a significant difference in the incidence of rotaviruses between different age groups (p = 0.3946). The prevalent RVA genotypes were G1P[8], G9P[8], G3P[8], G2P[4] and G8P[8]. The detection of the G8P[8] genotype was unusual. The obtained results show that despite the possibility of vaccination, the incidence of RVA infection remains high in the Czech Republic.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 4","pages":"140-144"},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37851216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Caring for women planning pregnancy or who are already pregnant: an infectious disease doctor's view]. [照顾计划怀孕或已经怀孕的妇女:传染病医生的观点]。
Q3 Medicine Pub Date : 2019-12-01
Věra Pellantová, Pavel Kosina, Šárka Rumlarová, Renata Kračmarová, Stanislav Plíšek

The article discusses possible prevention and prophylaxis of infectious diseases affecting the course of pregnancy with respect to the mother, fetus and newborn. Also mentioned are diseases for which there is no vaccination. The options for prevention targeted at the periods before and during pregnancy and after delivery are explained. Finally, practical procedures related to vaccination and diagnosis of infectious diseases in women of childbearing age are presented.

本文讨论了对母亲、胎儿和新生儿影响妊娠过程的传染病可能的预防和预防措施。还提到了没有接种疫苗的疾病。说明了针对怀孕前、怀孕期间和分娩后的预防办法。最后,介绍了与育龄妇女接种疫苗和诊断传染病有关的实际程序。
{"title":"[Caring for women planning pregnancy or who are already pregnant: an infectious disease doctor's view].","authors":"Věra Pellantová,&nbsp;Pavel Kosina,&nbsp;Šárka Rumlarová,&nbsp;Renata Kračmarová,&nbsp;Stanislav Plíšek","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article discusses possible prevention and prophylaxis of infectious diseases affecting the course of pregnancy with respect to the mother, fetus and newborn. Also mentioned are diseases for which there is no vaccination. The options for prevention targeted at the periods before and during pregnancy and after delivery are explained. Finally, practical procedures related to vaccination and diagnosis of infectious diseases in women of childbearing age are presented.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 4","pages":"125-131"},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37853288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparing traditional and commercial molecular biology detection of gastrointestinal pathogens with AusDiagnostics panels in Motol University Hospital]. [比较传统和商业化的胃肠道病原体分子生物学检测与摩拓大学医院AusDiagnostics面板]。
Q3 Medicine Pub Date : 2019-12-01
Aleš Briksí, Petr Hubáček, Jana Šumová, Veronika Nováková, Petra Chramostová, Radka Hornychová, Barbora Špatná, Miroslav Zajac

Background: The aim was to do an internal audit of gastrointestinal pathogen detection at the Department of Medical Microbiology, Motol University Hospital between the years 2014 and 2018 and to test two commercial multiplex molecular biology assays potentially improving the diagnostic process and reducing costs.

Material and methods: Based on data from a laboratory information system (LIS), a total of 45,888 samples were identified which had been tested for the presence of gastrointestinal pathogens using culture, immunochromatographic, microscopic and molecular biology techniques between 2014-2018. Novel multiplex molecular biology detection was used to test 182 nucleic acid isolates obtained from stool samples with the Enteric Viruses (8-well) assay (Viral Panel, EVP) or Faecal Pathogens M (16-well) assay (Microbial Panel, FPM) manufactured by AusDiagnostics.

Results: The LIS data showed 6.2 % of positive pathogens causing diarrhea from all tested samples (detection rates: 4.5 % for bacterial agents, 21.6 % for viral agents and 0.4 % for parasitic agents). Valid samples (98.9 % of all tested samples) tested by the molecular biology technique yielded, in descending order: C. difficile toxin B (19 %), norovirus (9 %), astrovirus (8 %), Campylobacter (7 %), sapovirus (6 %), Yersinia enterocolitica (6 %), rotavirus (4 %), enterovirus (3 %), Aeromonas (3 %), adenovirus (2 %) and Salmonella (1 %). There was found at least 1 additional new positive detection in 27 % of stools tested by the Viral Panel and in 40 % of stools tested by the Microbial Panel in comparison with the traditional approach. Introducing the panels into routine diagnostic practice will not reduce the costs.

Conclusions: The introduction of novel multiplex molecular biology assays for detecting gastrointestinal pathogens will considerably increase pathogen detection rates even though the costs will be higher for the Department of Medical Microbiology.

背景:目的是在2014年至2018年期间对Motol大学医院医学微生物学系的胃肠道病原体检测进行内部审计,并测试两种商业多重分子生物学检测方法,这些方法可能会改善诊断过程并降低成本。材料和方法:基于实验室信息系统(LIS)的数据,2014-2018年共鉴定了45,888份样本,并使用培养、免疫层析、显微镜和分子生物学技术检测了胃肠道病原体的存在。采用AusDiagnostics公司生产的肠道病毒(8孔)测定法(Viral Panel, EVP)或粪便病原体M(16孔)测定法(Microbial Panel, FPM),采用新型多重分子生物学检测方法对从粪便样本中分离出的182种核酸进行检测。结果:LIS数据显示,所有检测样本中引起腹泻的病原菌检出率为6.2%(细菌检出率为4.5%,病毒检出率为21.6%,寄生虫检出率为0.4%)。通过分子生物学技术检测的有效样品(占所有检测样品的98.9%),由高到低依次为:艰难梭菌毒素B(19%)、诺如病毒(9%)、星状病毒(8%)、弯曲杆菌(7%)、萨波病毒(6%)、小肠结肠炎耶尔森菌(6%)、轮状病毒(4%)、肠病毒(3%)、气单胞菌(3%)、腺病毒(2%)和沙门氏菌(1%)。与传统方法相比,27%的病毒小组检测的粪便和40%的微生物小组检测的粪便中至少发现了1个新的阳性检测。将面板引入常规诊断实践并不会降低成本。结论:引入新型的多重分子生物学检测方法检测胃肠道病原体,将大大提高病原体的检出率,尽管医学微生物科的成本会更高。
{"title":"[Comparing traditional and commercial molecular biology detection of gastrointestinal pathogens with AusDiagnostics panels in Motol University Hospital].","authors":"Aleš Briksí,&nbsp;Petr Hubáček,&nbsp;Jana Šumová,&nbsp;Veronika Nováková,&nbsp;Petra Chramostová,&nbsp;Radka Hornychová,&nbsp;Barbora Špatná,&nbsp;Miroslav Zajac","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The aim was to do an internal audit of gastrointestinal pathogen detection at the Department of Medical Microbiology, Motol University Hospital between the years 2014 and 2018 and to test two commercial multiplex molecular biology assays potentially improving the diagnostic process and reducing costs.</p><p><strong>Material and methods: </strong>Based on data from a laboratory information system (LIS), a total of 45,888 samples were identified which had been tested for the presence of gastrointestinal pathogens using culture, immunochromatographic, microscopic and molecular biology techniques between 2014-2018. Novel multiplex molecular biology detection was used to test 182 nucleic acid isolates obtained from stool samples with the Enteric Viruses (8-well) assay (Viral Panel, EVP) or Faecal Pathogens M (16-well) assay (Microbial Panel, FPM) manufactured by AusDiagnostics.</p><p><strong>Results: </strong>The LIS data showed 6.2 % of positive pathogens causing diarrhea from all tested samples (detection rates: 4.5 % for bacterial agents, 21.6 % for viral agents and 0.4 % for parasitic agents). Valid samples (98.9 % of all tested samples) tested by the molecular biology technique yielded, in descending order: C. difficile toxin B (19 %), norovirus (9 %), astrovirus (8 %), Campylobacter (7 %), sapovirus (6 %), Yersinia enterocolitica (6 %), rotavirus (4 %), enterovirus (3 %), Aeromonas (3 %), adenovirus (2 %) and Salmonella (1 %). There was found at least 1 additional new positive detection in 27 % of stools tested by the Viral Panel and in 40 % of stools tested by the Microbial Panel in comparison with the traditional approach. Introducing the panels into routine diagnostic practice will not reduce the costs.</p><p><strong>Conclusions: </strong>The introduction of novel multiplex molecular biology assays for detecting gastrointestinal pathogens will considerably increase pathogen detection rates even though the costs will be higher for the Department of Medical Microbiology.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 4","pages":"132-139"},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37853289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cryptococcal meningitis in an immunocompetent patient - a case report]. [1例免疫正常患者的隐球菌性脑膜炎- 1例报告]。
Q3 Medicine Pub Date : 2019-09-01
Melinda Tóthóvá, Dáša Nováková, Kristína Rogozánová, Ľubica Piesecká

Cryptococcal meningitis is a severe neurological infection caused by the yeast Cryptococcus neoformans. It often occurs as an opportunistic infection; rarely, it may be seen in healthy people as well. The most common source of the infection is inhalation of infected bird droppings. The cryptococci may persist in the lungs and nearby lymph nodes for a long time. There are no or mild clinical manifestations of the pulmonary infection. The disease often manifests only after the cryptococci penetrate into the CNS. The case report documents the development of cryptococcal meningitis in an immunocompetent patient. It was diagnosed by microscopic detection of the yeast in the cerebrospinal fluid. The finding was confirmed by detecting cryptococcal DNA in the cerebrospinal fluid and culture. Despite immediate initiation of antifungal therapy and intensive care, the patient died.

隐球菌性脑膜炎是一种由酵母隐球菌引起的严重神经系统感染。它通常作为机会性感染发生;在健康人身上也很少见。最常见的感染源是吸入受感染的禽鸟粪便。隐球菌可在肺部和附近淋巴结内存留很长时间。肺部感染无临床表现或表现轻微。这种疾病通常只有在隐球菌侵入中枢神经系统后才会出现。病例报告文件隐球菌脑膜炎的发展在免疫功能正常的病人。通过显微镜检测脑脊液中的酵母菌来诊断。通过检测脑脊液和培养物中的隐球菌DNA,证实了这一发现。尽管立即开始抗真菌治疗和重症监护,患者还是死亡了。
{"title":"[Cryptococcal meningitis in an immunocompetent patient - a case report].","authors":"Melinda Tóthóvá,&nbsp;Dáša Nováková,&nbsp;Kristína Rogozánová,&nbsp;Ľubica Piesecká","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cryptococcal meningitis is a severe neurological infection caused by the yeast Cryptococcus neoformans. It often occurs as an opportunistic infection; rarely, it may be seen in healthy people as well. The most common source of the infection is inhalation of infected bird droppings. The cryptococci may persist in the lungs and nearby lymph nodes for a long time. There are no or mild clinical manifestations of the pulmonary infection. The disease often manifests only after the cryptococci penetrate into the CNS. The case report documents the development of cryptococcal meningitis in an immunocompetent patient. It was diagnosed by microscopic detection of the yeast in the cerebrospinal fluid. The finding was confirmed by detecting cryptococcal DNA in the cerebrospinal fluid and culture. Despite immediate initiation of antifungal therapy and intensive care, the patient died.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 3","pages":"89-91"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37513681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Guidelines for treating HIV-infected adults and post-exposure prophylaxis for HIV infection]. [成人艾滋病毒感染者治疗和接触后艾滋病毒感染预防指南]。
Q3 Medicine Pub Date : 2019-09-01
Svatava Snopková, Hanuš Rozsypal, Viktor Aster, Dalibor Sedláček, Pavel Dlouhý, Jaroslav Kapla, David Jilich, Dan Veselý, Zdeňka Jerhotová, Lenka Olbrechtová, Alena Zjevíková, Milan Zlámal

Antiretroviral therapy represents an essential element in the approach to treatment and prevention of human immunodeficiency virus (HIV). It has changed the fatal disease to a manageable chronic condition and is the most effective prevention of its human-to-human transmission. Knowledge regarding biological characteristics of the virus, its behavior in a human host and our understanding of these phenomena have been extended by clinical experience, new clinical data and recent scientific progress. The development of new drugs becomes a modifier for the existing therapeutic strategy and preference. Certain points are more specific than in the previous guidelines. Definitions of certain clinical and laboratory conditions have been specified more accurately. The indications of specific antiretroviral agents and pitfalls of their use in lifelong antiretroviral treatment are also described more in detail. The document is a result of a general consensus among infectious disease specialists working with HIV patients in the Czech Republic. It should serve as a basic instrument for clinicians recommending treatment of HIV infection as well as a foundation for the society when dealing with both state authorities and health care payers.

抗逆转录病毒疗法是治疗和预防人体免疫缺陷病毒(艾滋病毒)方法中的一个基本要素。它已将这种致命疾病转变为可控制的慢性疾病,并且是最有效的人际传播预防措施。由于临床经验、新的临床数据和最近的科学进展,有关该病毒的生物学特性、其在人类宿主中的行为以及我们对这些现象的理解得到了扩展。新药的开发成为现有治疗策略和偏好的调节剂。某些要点比以前的指导方针更具体。某些临床和实验室条件的定义已被更准确地指定。具体的抗逆转录病毒药物的适应症和陷阱,他们在终身抗逆转录病毒治疗中使用也更详细地描述。该文件是捷克共和国与艾滋病毒患者一起工作的传染病专家达成普遍共识的结果。它应作为临床医生推荐艾滋病毒感染治疗的基本工具,以及社会在与国家当局和保健支付者打交道时的基础。
{"title":"[Guidelines for treating HIV-infected adults and post-exposure prophylaxis for HIV infection].","authors":"Svatava Snopková,&nbsp;Hanuš Rozsypal,&nbsp;Viktor Aster,&nbsp;Dalibor Sedláček,&nbsp;Pavel Dlouhý,&nbsp;Jaroslav Kapla,&nbsp;David Jilich,&nbsp;Dan Veselý,&nbsp;Zdeňka Jerhotová,&nbsp;Lenka Olbrechtová,&nbsp;Alena Zjevíková,&nbsp;Milan Zlámal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Antiretroviral therapy represents an essential element in the approach to treatment and prevention of human immunodeficiency virus (HIV). It has changed the fatal disease to a manageable chronic condition and is the most effective prevention of its human-to-human transmission. Knowledge regarding biological characteristics of the virus, its behavior in a human host and our understanding of these phenomena have been extended by clinical experience, new clinical data and recent scientific progress. The development of new drugs becomes a modifier for the existing therapeutic strategy and preference. Certain points are more specific than in the previous guidelines. Definitions of certain clinical and laboratory conditions have been specified more accurately. The indications of specific antiretroviral agents and pitfalls of their use in lifelong antiretroviral treatment are also described more in detail. The document is a result of a general consensus among infectious disease specialists working with HIV patients in the Czech Republic. It should serve as a basic instrument for clinicians recommending treatment of HIV infection as well as a foundation for the society when dealing with both state authorities and health care payers.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 3","pages":"97-120"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37513683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of PCR for diagnosing cat-scratch disease]. 【PCR诊断猫抓病的应用】。
Q3 Medicine Pub Date : 2019-09-01
Lubomíra Hozáková, Luděk Rožnovský, Jarmila Šímová, Jakub Mrázek, Vladimír Janout

Objective: The diagnosis of Bartonella henselae by polymerase chain reaction (PCR) in lymph nodes removed in 10 patients with serologically confirmed evidence cat-scratch disease.

Material and methods: The 2015-2018 group consisted of 10 patients with serologically confirmed cat-scratch disease, all of them having positive IgG antibodies and 6 patients also positive IgM antibodies against B. henselae. The group included 4 men and 6 women, 7 children and 3 adults, aged 5-52 years. Eleven lymph nodes obtained from the 10 patients were formalin-fixed paraffin-embedded. Variants of granulomatous inflammation were found in 9 patients; a 13-year-old boy had Hodgkin's lymphoma. DNA isolation was performed with cobas® DNA Sample Preparation Kit (Roche). DNA of Bartonella spp. was detected by real-time PCR with BactoReal® Kit Bartonella spp. (Ingenetix) detecting the gltA gene specific for the genus Bartonella.

Results: Four of the 10 patients tested positive or borderline positive for Bartonella when their histological material was analyzed by PCR. One patient with 2 lymph nodes examined showed a positive result for only 1 lymph node. One adult male had a positive result; three children showed borderline positive results. Of those, two patients had suppurative granulomatous and the other 2 patients had necrotizing suppurative granulomatous inflammation as histological findings. All 4 patients had positive IgM antibodies against B. henselae. The boy with lymphoma had a negative PCR result.

Conclusion: Serological tests combined with histological examination of lymph nodes and PCR may improve the diagnosis of cat- scratch disease.

目的:应用聚合酶链式反应(PCR)对10例血清学证实为猫抓病的患者淋巴结活检诊断亨塞巴尔通体。材料与方法:2015-2018年组为血清学确诊的猫抓病患者10例,均为IgG抗体阳性,其中6例为B. henselae IgM抗体阳性。其中男性4名,女性6名,儿童7名,成人3名,年龄5-52岁。10例患者11个淋巴结采用福尔马林固定石蜡包埋。9例发现肉芽肿性炎症变异;一个13岁的男孩得了霍奇金淋巴瘤。采用cobas®DNA样品制备试剂盒(Roche)进行DNA分离。采用实时荧光定量PCR检测巴尔通体的DNA,采用BactoReal®Kit Bartonella spp. (Ingenetix)检测巴尔通体属特异性gltA基因。结果:10例患者中4例巴尔通体检测呈阳性或临界阳性,经PCR分析。1例2个淋巴结的患者仅1个淋巴结检查阳性。一名成年男性检测结果为阳性;三个孩子的结果呈阳性。其中2例为化脓性肉芽肿,2例为坏死性化脓性肉芽肿性炎症。4例患者抗henselae B. IgM抗体均阳性。淋巴瘤男孩的PCR结果为阴性。结论:血清学检查结合淋巴结组织学检查和PCR可提高猫抓病的诊断。
{"title":"[Use of PCR for diagnosing cat-scratch disease].","authors":"Lubomíra Hozáková,&nbsp;Luděk Rožnovský,&nbsp;Jarmila Šímová,&nbsp;Jakub Mrázek,&nbsp;Vladimír Janout","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The diagnosis of Bartonella henselae by polymerase chain reaction (PCR) in lymph nodes removed in 10 patients with serologically confirmed evidence cat-scratch disease.</p><p><strong>Material and methods: </strong>The 2015-2018 group consisted of 10 patients with serologically confirmed cat-scratch disease, all of them having positive IgG antibodies and 6 patients also positive IgM antibodies against B. henselae. The group included 4 men and 6 women, 7 children and 3 adults, aged 5-52 years. Eleven lymph nodes obtained from the 10 patients were formalin-fixed paraffin-embedded. Variants of granulomatous inflammation were found in 9 patients; a 13-year-old boy had Hodgkin's lymphoma. DNA isolation was performed with cobas® DNA Sample Preparation Kit (Roche). DNA of Bartonella spp. was detected by real-time PCR with BactoReal® Kit Bartonella spp. (Ingenetix) detecting the gltA gene specific for the genus Bartonella.</p><p><strong>Results: </strong>Four of the 10 patients tested positive or borderline positive for Bartonella when their histological material was analyzed by PCR. One patient with 2 lymph nodes examined showed a positive result for only 1 lymph node. One adult male had a positive result; three children showed borderline positive results. Of those, two patients had suppurative granulomatous and the other 2 patients had necrotizing suppurative granulomatous inflammation as histological findings. All 4 patients had positive IgM antibodies against B. henselae. The boy with lymphoma had a negative PCR result.</p><p><strong>Conclusion: </strong>Serological tests combined with histological examination of lymph nodes and PCR may improve the diagnosis of cat- scratch disease.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 3","pages":"84-88"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37513680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Linezolid-induced lactic acidosis - a brief overview with a case report]. [利奈唑胺引起的乳酸酸中毒-附病例报告的简要概述]。
Q3 Medicine Pub Date : 2019-09-01
Jana Pazderkovák, Vladislav Kotora, Pavel Dlouhý, Hynek Bartoš

Lactic acidosis is a rare but serious adverse event linked to treatment with linezolid, an oxazolidinone antibiotic. Presented is a case of a 67-year-old man treated for 26 days with linezolid for staphylococcal osteomyelitis of the right foot with subsequent sepsis. During the course of treatment, severe lactic acidosis developed, requiring hospitalization in an intensive care unit. The likely mechanism of this potentially life-threatening complication is discussed.

乳酸性酸中毒是一种罕见但严重的不良事件,与利奈唑胺治疗有关,利奈唑胺是一种恶唑烷类抗生素。本文报告一例67岁男性患者,因右脚葡萄球菌性骨髓炎并发脓毒症接受利奈唑胺治疗26天。在治疗过程中,发生了严重的乳酸酸中毒,需要在重症监护病房住院治疗。讨论了这种可能危及生命的并发症的可能机制。
{"title":"[Linezolid-induced lactic acidosis - a brief overview with a case report].","authors":"Jana Pazderkovák,&nbsp;Vladislav Kotora,&nbsp;Pavel Dlouhý,&nbsp;Hynek Bartoš","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lactic acidosis is a rare but serious adverse event linked to treatment with linezolid, an oxazolidinone antibiotic. Presented is a case of a 67-year-old man treated for 26 days with linezolid for staphylococcal osteomyelitis of the right foot with subsequent sepsis. During the course of treatment, severe lactic acidosis developed, requiring hospitalization in an intensive care unit. The likely mechanism of this potentially life-threatening complication is discussed.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 3","pages":"92-96"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37513682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Invasive aspergillosis in "nonimmunocompromised" patients (case reports)]. [非免疫功能低下患者的侵袭性曲霉病(病例报告)]。
Q3 Medicine Pub Date : 2019-06-01
Ľbomír Soják

Invasive aspergillosis (IA) is a major cause of morbidity and mortality in immunocompromised patients. Given the rising numbers of patients at risk of opportunistic infections, there has been a significant increase in Aspergillus infections in recent years. Patients most at risk are mainly those with prolonged neutropenia or receiving long-term corticosteroid or other immunosuppressive thera pies and those with impaired pulmonary defense. Relatively recently, critically ill patients without traditional risk factors were also classified as at-risk, that is patients in intensive care units, those with chronic obstructive pulmonary disease, post-flu and so on. Chronic obstructive pulmonary disease is one of the most common predisposing conditions due to frequent Aspergillus airway colonization. Other significant risk factors for IA are decompensated liver disease and cirrhosis, AIDS, corticosteroid treatment, impaired mucociliary transport after cure from pneumonia (both bacterial and viral), immune deficiency in long-lasting diseases and autoimmune disorders. Additionally, various immunosuppressive drugs increase the risk of IA (e.g. tumor necrosis factor blockers). The case reports describe two patients who developed disseminated aspergillosis after a severe illness, with the right diagnosis being made only at autopsy. The author´s aim is to draw attention to the need to consider IA also in patients who initially do not appear to be at risk for disseminated fungal infection.

侵袭性曲霉病(IA)是免疫功能低下患者发病和死亡的主要原因。鉴于越来越多的患者面临机会性感染的风险,近年来曲霉感染有显著增加。最危险的患者主要是长期中性粒细胞减少或长期接受皮质类固醇或其他免疫抑制治疗的患者以及肺防御受损的患者。最近,没有传统危险因素的危重患者也被列为高危患者,即重症监护病房的患者、慢性阻塞性肺病患者、流感后患者等。慢性阻塞性肺疾病是最常见的易感条件之一,由于频繁的曲霉气道定植。IA的其他重要危险因素包括失代偿性肝病和肝硬化、艾滋病、皮质类固醇治疗、肺炎(细菌性和病毒性)治愈后粘膜纤毛运输受损、长期疾病的免疫缺陷和自身免疫性疾病。此外,各种免疫抑制药物(如肿瘤坏死因子阻滞剂)会增加IA的风险。病例报告描述了两名在严重疾病后出现播散性曲霉病的患者,只有在尸检时才能做出正确的诊断。作者的目的是提请注意,需要考虑IA患者最初似乎没有播散性真菌感染的风险。
{"title":"[Invasive aspergillosis in \"nonimmunocompromised\" patients (case reports)].","authors":"Ľbomír Soják","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Invasive aspergillosis (IA) is a major cause of morbidity and mortality in immunocompromised patients. Given the rising numbers of patients at risk of opportunistic infections, there has been a significant increase in Aspergillus infections in recent years. Patients most at risk are mainly those with prolonged neutropenia or receiving long-term corticosteroid or other immunosuppressive thera pies and those with impaired pulmonary defense. Relatively recently, critically ill patients without traditional risk factors were also classified as at-risk, that is patients in intensive care units, those with chronic obstructive pulmonary disease, post-flu and so on. Chronic obstructive pulmonary disease is one of the most common predisposing conditions due to frequent Aspergillus airway colonization. Other significant risk factors for IA are decompensated liver disease and cirrhosis, AIDS, corticosteroid treatment, impaired mucociliary transport after cure from pneumonia (both bacterial and viral), immune deficiency in long-lasting diseases and autoimmune disorders. Additionally, various immunosuppressive drugs increase the risk of IA (e.g. tumor necrosis factor blockers). The case reports describe two patients who developed disseminated aspergillosis after a severe illness, with the right diagnosis being made only at autopsy. The author´s aim is to draw attention to the need to consider IA also in patients who initially do not appear to be at risk for disseminated fungal infection.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 2","pages":"43-47"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37571415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicka mikrobiologie a infekcni lekarstvi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1